Pharmaceutical Excipients Market Worth $8,439.0 Million by 2019

Jul 10, 2015, 12:00 ET from MarketsandMarkets

DALLAS, July 10, 2015 /PRNewswire/ --

According to a new market research report "Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals), Functionality (Fillers, Binders, Lubricants, Preservatives), & by Route of Administration (Oral, Topical, Parenteral, Others) - Global Forecast to 2019", published by MarketsandMarkets, The Pharmaceutical Excipients Market is expected to reach around $8,439.0 Million by 2019 at a CAGR of 6.7% during the forecast period from 2015 to 2019.

Browse 199 market data Tables and 41 Figures spread through 270 Pages and in-depth TOC on "Pharmaceutical Excipients Market"

Early buyers will receive 10% customization on this report. 

The pharmaceutical excipients market is highly fragmented, with none of the major players accounting for more than 10% of the market share. The market comprises of several small players, each accounting for a market share of less than 1%. A majority of these small players are based across low-cost manufacturing locations such as China, India, and Brazil.

Inquiry before Buying:

The global pharmaceutical excipients market was majorly dominated by North America in 2013. This market will continue to drive and dominate the pharmaceutical excipients market by 2019. Increased focus on outsourcing of manufacturing activities by companies in North America to facilities in Asian nations and in some Latin American countries will slightly reduce the share of North America by 2019. The growth of the Asian market will primarily be driven by countries like India and China. This is mainly attributed to the rising demand for healthcare driven by growth in per capita income, and increasing excipients manufacturing outsourced by companies in developed nations. The European market is expected to grow at a higher pace than North America mainly due to increasing investments in drug development and continuous efforts of pharmaceutical companies to offer superior-quality products.

Expansions, new product launches, and mergers and collaborations were the key strategies adopted by most companies in the global pharmaceutical excipients market in 2013 and 2014. Broad research in this market has brought into view that expansion strategy is the key strategy followed by major players accounting for a share of nearly 28% of the total strategies. Increasing demand of excipients and high growth potential offered by the emerging markets has resulted in increasing number of companies focusing on expansion into pharma-emerging markets. The key players involved in expansions are Ashland, Inc. (U.S.), BASF SE (Germany), the Dow Chemical Company (U.S.), Roquette (France), and FMC Corporation (U.S.).  The pharmaceutical industry's need for novel functional excipients formed the basis for innovations in the market during the forecast period. By adopting this strategy, leading players launched various advanced excipients such as multifunctional excipients and co-processed excipients into the market. Furthermore, the market players also launched modified grades of existing pharmaceutical excipients in the market.

Ashland, Inc. (U.S.), and BASF (Germany) were the leading players in the pharmaceutical excipients market with market shares of approximately 9.5% and 9.3% respectively in 2013. Ashland has a diversified product portfolio, which includes a wide range of tablet binding, tablet disintegration, tablet film coating, solubilizer, and rheology modifier excipients. Ashland's leading position in the market is attributed to its strong manufacturing and distribution footprint across the world, which enables it to serve customers in more than 100 countries.

Browse Related Reports: 

Pharmaceutical Packaging Market by Packaging Type, by Raw Material, by Drug Delivery Type by Region(North America, Europe, Asia-Pacific, RoW) - Forecasts to 2020

Pharmaceutical Grade Sodium Chloride Market by Applications (injections, oral rehydration salt (ORS), hemodialysis, peritoneal dialysis, & hemofiltration solutions, channeling agents/ osmotic agent, mechanical cleansing solutions, dietary formulations and infant formulations), by Region - Industry Trends & Forecasts to 2019

About MarketsandMarkets

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @

SOURCE MarketsandMarkets